1. NAMPT-derived NAD+ fuels PARP1 to promote skin inflammation through parthanatos cell death.
- Author
-
Martínez-Morcillo FJ, Cantón-Sandoval J, Martínez-Navarro FJ, Cabas I, Martínez-Vicente I, Armistead J, Hatzold J, López-Muñoz A, Martínez-Menchón T, Corbalán-Vélez R, Lacal J, Hammerschmidt M, García-Borrón JC, García-Ayala A, Cayuela ML, Pérez-Oliva AB, García-Moreno D, and Mulero V
- Subjects
- Animals, Apoptosis Inducing Factor metabolism, Cell Nucleus drug effects, Cell Nucleus metabolism, Cell Proliferation drug effects, DNA Damage, Disease Models, Animal, Gene Expression Regulation drug effects, Inflammation genetics, Keratinocytes drug effects, Keratinocytes metabolism, Keratinocytes pathology, Larva metabolism, NADPH Oxidases antagonists & inhibitors, NADPH Oxidases metabolism, Nicotinamide Phosphoribosyltransferase antagonists & inhibitors, Oxidative Stress drug effects, Oxidative Stress genetics, Poly Adenosine Diphosphate Ribose metabolism, Poly(ADP-ribose) Polymerase Inhibitors pharmacology, Proteinase Inhibitory Proteins, Secretory deficiency, Proteinase Inhibitory Proteins, Secretory metabolism, Psoriasis genetics, Psoriasis pathology, Reactive Oxygen Species metabolism, Zebrafish, Zebrafish Proteins deficiency, Zebrafish Proteins metabolism, Inflammation pathology, NAD metabolism, Nicotinamide Phosphoribosyltransferase metabolism, Parthanatos drug effects, Parthanatos genetics, Poly(ADP-ribose) Polymerases metabolism, Skin pathology
- Abstract
Several studies have revealed a correlation between chronic inflammation and nicotinamide adenine dinucleotide (NAD+) metabolism, but the precise mechanism involved is unknown. Here, we report that the genetic and pharmacological inhibition of nicotinamide phosphoribosyltransferase (Nampt), the rate-limiting enzyme in the salvage pathway of NAD+ biosynthesis, reduced oxidative stress, inflammation, and keratinocyte DNA damage, hyperproliferation, and cell death in zebrafish models of chronic skin inflammation, while all these effects were reversed by NAD+ supplementation. Similarly, genetic and pharmacological inhibition of poly(ADP-ribose) (PAR) polymerase 1 (Parp1), overexpression of PAR glycohydrolase, inhibition of apoptosis-inducing factor 1, inhibition of NADPH oxidases, and reactive oxygen species (ROS) scavenging all phenocopied the effects of Nampt inhibition. Pharmacological inhibition of NADPH oxidases/NAMPT/PARP/AIFM1 axis decreased the expression of pathology-associated genes in human organotypic 3D skin models of psoriasis. Consistently, an aberrant induction of NAMPT and PARP activity, together with AIFM1 nuclear translocation, was observed in lesional skin from psoriasis patients. In conclusion, hyperactivation of PARP1 in response to ROS-induced DNA damage, fueled by NAMPT-derived NAD+, mediates skin inflammation through parthanatos cell death., Competing Interests: I have read the journal policy’s and the authors of this manuscript have the following competing interests: A patent for the use of parthanatos inhibitors to treat psoriasis and atopic dermatitis has been registered by Universidad de Murcia and Instituto Murciano de Investigación Biosanitaria (#PCT/EP2020/083380).
- Published
- 2021
- Full Text
- View/download PDF